ALUMIS INC. (ALMS)
Latest ALMS Insider Trades
About ALUMIS INC. (ALMS)
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
- SOUTH SAN FRANCISCO, CA
- 239
- 2024
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 7 | 19,953 | $534K |
| Grant or award | 10 | 95,405 | |
| Option exercise | 2 | 10,000 |
ALMS Insider Transactions (Form 4)
5351 Form 4 filings on record, the earliest from May 6, 2025, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John R. Schroer - Officer | Open-market sale | Common Stock | 3,282 |
Recent ALMS Form 8-K Filings
5Recent ALMS Form 144 Notices of Proposed Sale
1A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
ALMS Insider Trading - FAQ
What is the latest insider trade for ALMS?
ALUMIS INC. (ALMS) had 12 insider filings in the last 90 days, with the most recent on 2026-08-05. The full record for ALMS runs to 51 Form 4 filings, the earliest from 2025-05-06. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying ALMS stock?
No insider purchases of ALMS were filed in the last 90 days. 30 purchases are on record for this company.
How many insiders are selling ALMS stock?
7 insider sales of ALMS were filed in the last 90 days, totaling $534K.
Where can I see ALMS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks ALMS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow ALMS insider buys?
Create a free InsiderAlpha account and press Watch on this page to add ALMS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - John R. Schroer view on EDGAR
- - Sanam Pangali view on EDGAR
- - Roy C. Hardiman view on EDGAR
- - David M. Goldstein view on EDGAR
- - Jorn Drappa view on EDGAR
- - Mark Christopher Bradley view on EDGAR
- - Sanam Pangali view on EDGAR
- - Lynn A. Tetrault view on EDGAR
- - Zhengbin Yao view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where ALMS's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track ALMS insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.